Chief Commercial Officer
With more than 25 years of commercial leadership experience in the pharmaceutical industry, Peter Karas has spearheaded business development, marketing, and sales for organizations all over the globe. From Xellia Pharmaceuticals to Baxter to Fresenius Kabi, Pete’s influence has built robust product portfolios and created successful teams. Joining Long Grove in 2021, Pete is redefining the power of generic drugs—one reformulation at a time.
Q: What about the market excites you?
What possibilities are in the future?
A: I enjoy all the people in the industry and learning from them. There are so many facets to the business, and I feel like I am constantly learning something new by engaging with the various players.
Q: Share with us about your journey to Long Grove; what are you bringing from your past?
A: I have had the opportunity to work at several great companies in a variety of roles working with some phenomenal people. This experience has allowed me to learn the business upstream and downstream and understand the importance of strong individuals working together as a team.
Q: What sets Long Grove apart?
A: Capstone/Long Grove is a team of established players with an entrepreneurial mindset.